WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents

被引：0

作者：

Ponnou, Sebastien ^{[1
]}

Timimi, Sami ^{[1
]}

Briffault, Xavier ^{[2
]}

Batstra, Laura ^{[3
]}

Gotzsche, Peter C. ^{[4
]}

Gonon, Francois ^{[5
]}

机构：

[1] Univ Paris 08, Educ Sci, CIRCEFT, CLEF,EA 4384, F-93200 St Denis, France

[2] Univ Paris Cite, Ctr Res Med Sci Hlth Mental Hlth & Soc CERMES3, Natl Ctr Sci Res, Paris, France

[3] Univ Groningen, Fac Behav & Social Sci, Dept Child & Family Welf, Groningen, Netherlands

[4] Inst Sci Freedom, Copenhagen, Denmark

[5] Univ Bordeaux, Natl Ctr Sci Res, Inst Neurodegenerat Dis, Bordeaux, France

来源：

LANCET PSYCHIATRY | 2024年 / 11卷 / 02期

关键词：

FOLLOW-UP;

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：92 / 93

页数：2

共 10 条

[1] Coghill D, 2023, LANCET PSYCHIAT, V10, P743, DOI [10.10665/364129/WHOEMMNH214E-eng, 10.1016/S2215-0366(23)00292-4]
[2] Currie J., 2013, NBER WORKING PAPER SERIES DIAGNOSIS AND UNNECESSARY PROCEDURE USE: EVIDENCE FROM C-SECTION We thank Samantha Heep and Dawn Ko man for excellent research assistance Diagnosis and Unnecessary Procedure Use: Evidence from C-Section
[3] Government of Western Australia Department of Health, 2010, Raine ADHD study: long-term outcomes associated with stimulant medication in the treatment of ADHD in children
[4] Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI [10.1097/CHI.0b013e3180686d48, 10.1097/chi.0b013e3180686d48]
[5] The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study
Molina, Brooke S. G.
Hinshaw, Stephen P.
Swanson, James M.
Arnold, L. Eugene
Vitiello, Benedetto
Jensen, Peter S.
Epstein, Jeffery N.
Hoza, Betsy
Hechtman, Lily
Abikoff, Howard B.
Elliott, Glen R.
Greenhill, Laurence L.
Newcorn, Jeffrey H.
Wells, Karel C.
Wigal, Timothy
Gibbons, Robert D.
Hur, Kwan
Houck, Patricia R.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (05) : 484 - 500
[6] Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020
Shearer, Riley D.
Jones, Abenaa
Howell, Benjamin A.
Segel, Joel E.
Winkelman, Tyler N. A.
[J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 143
[7] Storebo OJ, 2023, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009885.pub3, 10.1002/14651858.CD009885.pub2]
[8] Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials
Storebo, Ole Jakob
Krogh, Helle B.
Ramstad, Erica
Moreira-Maia, Carlos R.
Holmskov, Mathilde
Skoog, Maria
Nilausen, Trine Danvad
Magnusson, Frederik L.
Zwi, Morris
Gillies, Donna
Rosendal, Susanne
Groth, Camilla
Rasmussen, Kirsten Buch
Gauci, Dorothy
Kirubakaran, Richard
Forsbol, Bente
Simonsen, Erik
Gluud, Christian
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[9] Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression
Swanson, James M.
Arnold, L. Eugene
Molina, Brooke S. G.
Sibley, Margaret H.
Hechtman, Lily T.
Hinshaw, Stephen P.
Abikoff, Howard B.
Stehli, Annamarie
Owens, Elizabeth B.
Mitchell, John T.
Nichols, Quyen
Howard, Andrea
Greenhill, Laurence L.
Hoza, Betsy
Newcorn, Jeffrey H.
Jensen, Peter S.
Vitiello, Benedetto
Wigal, Timothy
Epstein, Jeffery N.
Tamm, Leanne
Lakes, Kimberly D.
Waxmonsky, James
Lerner, Marc
Etcovitch, Joy
Murray, Desiree W.
Muenke, Maximilian
Acosta, Maria T.
Arcos-Burgos, Mauricio
Pelham, William E.
Kraemer, Helena C.
[J]. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2017, 58 (06) : 663 - 678
[10] WHO, 2023, A.21 Methylphenidate-attention- deficit hyperactivity disorder-EML and EMLc

← 1 →